Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.

Source:http://linkedlifedata.com/resource/pubmed/id/2785435

Cancer Res. 1989 May 15 49 10 2639-44

Download in:

View as

General Info

PMID
2785435